Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.0560
0.00 (0.00%)
Apr 14, 2026, 4:00 PM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $4.34 million as of April 16, 2026.
Market Cap
4.34M
Enterprise Value
5.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since July 27, 2021, Biomind Labs's market cap has decreased from 18.69M to 4.34M, a decrease of -76.76%. That is a compound annual growth rate of -26.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 4.34M | -50.88% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | 18.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 5.95M |
| Orgenesis | 5.87M |
| AccuStem Sciences | 5.54M |
| Nymox Pharmaceutical | 5.10M |
| Bioxytran | 5.10M |
| Mosaic ImmunoEngineering | 5.03M |
| GPL Holdings | 4.17M |
| Burzynski Research Institute | 3.29M |